Ju‐Tao Guo

10.7k total citations · 1 hit paper
120 papers, 8.3k citations indexed

About

Ju‐Tao Guo is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Ju‐Tao Guo has authored 120 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Epidemiology, 71 papers in Hepatology and 48 papers in Infectious Diseases. Recurrent topics in Ju‐Tao Guo's work include Hepatitis B Virus Studies (80 papers), Hepatitis C virus research (71 papers) and interferon and immune responses (24 papers). Ju‐Tao Guo is often cited by papers focused on Hepatitis B Virus Studies (80 papers), Hepatitis C virus research (71 papers) and interferon and immune responses (24 papers). Ju‐Tao Guo collaborates with scholars based in United States, China and Canada. Ju‐Tao Guo's co-authors include Timothy M. Block, Jinhong Chang, Haitao Guo, Christoph Seeger, Andrea Cuconati, Dong Jiang, V. Bichko, Xuesen Zhao, Tianlun Zhou and Dawei Cai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Ju‐Tao Guo

118 papers receiving 8.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication

1997 517 citations Ju‐Tao Guo, Christoph Seeger et al. profile →

Peers

Countries citing papers authored by Ju‐Tao Guo

Since Specialization

Citations

This map shows the geographic impact of Ju‐Tao Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju‐Tao Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju‐Tao Guo more than expected).

Fields of papers citing papers by Ju‐Tao Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju‐Tao Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju‐Tao Guo. The network helps show where Ju‐Tao Guo may publish in the future.

Co-authorship network of co-authors of Ju‐Tao Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ju‐Tao Guo. A scholar is included among the top collaborators of Ju‐Tao Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju‐Tao Guo. Ju‐Tao Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein 2025 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), (unknown), David M. Renner, Jiaqi Li, Gideon F. Tolufashe, Yanming Du, Ju‐Tao Guo, Jinhong Chang	0
2	Computational Approaches to Predict Hepatitis B Virus Capsid Protein Mutations That Confer Resistance to Capsid Assembly Modulators 2025 ·Viruses ·Gideon F. Tolufashe, (unknown), John L. Kulp, Ju‐Tao Guo	1
3	Discovery of hepatitis B virus subviral particle biogenesis inhibitors from a bioactive compound library 2024 ·Antiviral Research ·(unknown), Sisi Yang, Lauren E. Griffith, Julia Ma, (unknown), Hui Liu, Qiong Zhao, Yanming Du, Jiming Zhang, Jinhong Chang, Ju‐Tao Guo	0
4	Mechanism of interferon alpha therapy for chronic hepatitis B and potential approaches to improve its therapeutic efficacy 2023 ·Antiviral Research ·Qiong Zhao, Hui Liu, Liudi Tang, (unknown), Gideon F. Tolufashe, Jinhong Chang, Ju‐Tao Guo	32
5	A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response 2022 ·PLoS Pathogens ·(unknown), (unknown), (unknown), Shuo Wu, Julia Ma, (unknown), Yan Zhou, Xinghong Dai, Esther Bullitt, Yanming Du, Ju‐Tao Guo, Jinhong Chang	16
6	Hepatitis B virus nucleocapsid uncoating: biological consequences and regulation by cellular nucleases 2021 ·Emerging Microbes & Infections ·Jin Hu, Liudi Tang, Junjun Cheng, Tianlun Zhou, Yuhuan Li, Jinhong Chang, Qiong Zhao, Ju‐Tao Guo	23
7	Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis 2021 ·PLoS Pathogens ·Hui Liu, Junjun Cheng, (unknown), Jinhong Chang, Fengmin Lu, Ju‐Tao Guo	14
8	Restoration of a functional antiviral immune response to chronic HBV infection by reducing viral antigen load: if not sufficient, is it necessary? 2021 ·Emerging Microbes & Infections ·Sisi Yang, (unknown), Jing Zhang, Fengmin Lu, Jinhong Chang, Ju‐Tao Guo	20
9	[Clinical cure strategies for hepatitis B: direct-acting antiviral drugs]. 2020 ·PubMed ·(unknown), Zhenghong Yuan, Yuemin Nan, (unknown), Ju‐Tao Guo, (unknown)	2
10	Discovery and Mechanistic Study of a Novel Human-Stimulator-of-Interferon-Genes Agonist 2019 ·ACS Infectious Diseases ·Xiaohui Zhang, Bowei Liu, Liudi Tang, Qing Su, (unknown), Mohit Sehgal, Junjun Cheng, Julia Ma, Xuexiang Zhang, Yinfei Tan, Yan Zhou, Zhongping Duan, Victor R. DeFilippis, (unknown), John L. Kulp, Yanming Du, Ju‐Tao Guo, Jinhong Chang	54
11	CpAMs induce assembly of HBV capsids with altered electrophoresis mobility: Implications for mechanism of inhibiting pgRNA packaging 2018 ·Antiviral Research ·Shuo Wu, Yue Luo, (unknown), John L. Kulp, Junjun Cheng, Zhanying Hu, Qifang Xu, Yan Zhou, Guozhong Gong, Jinhong Chang, Yuhuan Li, Ju‐Tao Guo	23
12	Discovery of Novel Hepatitis B Virus Nucleocapsid Assembly Inhibitors 2018 ·ACS Infectious Diseases ·Xuexiang Zhang, Junjun Cheng, Julia Ma, Zhanying Hu, Shuo Wu, (unknown), John L. Kulp, Yanming Du, Ju‐Tao Guo, Jinhong Chang	41
13	A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists 2017 ·Antiviral Research ·Bowei Liu, Liudi Tang, Xiaohui Zhang, Julia Ma, Mohit Sehgal, Junjun Cheng, Xuexiang Zhang, Yan Zhou, Yanming Du, John L. Kulp, Ju‐Tao Guo, Jinhong Chang	61
14	Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo 2017 ·Antiviral Research ·Julia Ma, Xuexiang Zhang, Veronica Soloveva, Travis K. Warren, Fang Guo, Shuo Wu, (unknown), Jia Guo, Qing Su, (unknown), Eric Solon, Mary Ann Comunale, Anand S. Mehta, Ju‐Tao Guo, Sina Bavari, Yanming Du, Timothy M. Block, Jinhong Chang	24
15	Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA 2017 ·PLoS Pathogens ·Yuanjie Liu, Hui Nie, Richeng Mao, Bidisha Mitra, Dawei Cai, Ran Yan, Ju‐Tao Guo, Timothy M. Block, Nadir Mechti, Haitao Guo	103
16	Interferon-inducible ribonuclease ISG20 inhibits hepatitis B virus replication through directly binding to the epsilon stem-loop structure of viral RNA 2017 ·PMC ·Yuanjie Liu, Hui Nie, Richeng Mao, Bidisha Mitra, Dawei Cai, Ran Yan, Ju‐Tao Guo, Timothy M. Block, Nadir Mechti, Haitao Guo	1
17	HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways 2017 ·PLoS Pathogens ·Fang Guo, Qiong Zhao, Muhammad Sheraz, Junjun Cheng, Yonghe Qi, Qing Su, Andrea Cuconati, Lai Wei, Yanming Du, Wenhui Li, Jinhong Chang, Ju‐Tao Guo	97
18	The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion 2015 ·PMC ·Ran Yan, Xuesen Zhao, Dawei Cai, (unknown), Timothy M. Block, Ju‐Tao Guo, Haitao Guo	1
19	Antiviral activities of ISG20 in positive-strand RNA virus infections 2010 ·Virology ·Zhi Zhou, Nan Wang, (unknown), Qingming Dong, Jie Wang, Yuqiong Liang, René Rijnbrand, Lai Wei, Joan E. Nichols, Ju‐Tao Guo, Michael R. Holbrook, Stanley M. Lemon, Kui Li	81
20	Mechanism of the interferon alpha response against hepatitis C virus replicons 2004 ·Virology ·Ju‐Tao Guo, Ji A. Sohn, Qing Zhu, Christoph Seeger	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact